Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5
- 12 March 2001
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (5), 741-745
- https://doi.org/10.1016/s0960-894x(01)00051-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Design, synthesis and binding affinities of novel non-peptide mimics of somatostatin/sandostatin®Bioorganic & Medicinal Chemistry Letters, 1996
- A non-peptide ligand for the somatostatin receptor having a benzodiazepinone structureBioorganic & Medicinal Chemistry Letters, 1996
- Three-Dimensional Quantitative Structure-Activity Relationships of Somatostatin Analogs. 1. Comparative Molecular Field Analysis of Growth Hormone Release-Inhibiting PotenciesJournal of Medicinal Chemistry, 1995
- Potent Inhibitory Effects of a Type Four Receptor-Selective Somatostatin Analog on Rat Insulin ReleaseBiochemical and Biophysical Research Communications, 1993
- Design, synthesis, and binding affinity of a nonpeptide mimic of somatostatinBioorganic & Medicinal Chemistry Letters, 1992
- Somatostatin in the central nervous system: Physiology and pathological modificationsProgress in Neurobiology, 1986
- A super active cyclic hexapeptide analog of somatostatinLife Sciences, 1984
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Highly active cyclic and bicyclic somatostatin analogues of reduced ring sizeNature, 1979
- INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONEThe Lancet, 1974